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Dehydrophenylalanine (,dPhe) was incorporated into an antibiotic peptide gramicidin S (GS) in place of 
D-Phe 4'4' to prepare an unsaturated analog. Conformational nalysis with 1H-NMR indicated that the un- 
saturated analog has much the same backbone conformation as that of natural gramicidin S as shown by 
NOE experiments. Studies on temperature d pendences and on the chemical shift differences showed that 
the hydrogen bonds between VaI-NH and Leu-CO in the unsaturated analog are strengthened by the incor- 
poration of APh¢ 4'4'. This resulted in the reinforcement of the fl-sheet structure which is the most important 
structural element for GS bioactivity. [3Phe4'4"]gramicidin S exhibited indeed very strong antimicrobial cti- 
vities against Gram-positive bacteria s well as the natural peptide. 
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1. INTRODUCTION 
Simple orgY-dehydrogenation of an amino acid 
residue in bioactive peptides, creating an c~fl- 
dehydroamino acid residue, has become of con- 
siderable interest due to the unique effect of this 
structural variation on structure-activity relation- 
ships [1]. Such modifications can elicit some con- 
formational changes, i.e. increase in rigidity due to 
the limited bond angles of the residue, restriction 
of  side chain orientations, and induction of 
folding. Another advantage in these modifications 
is the enhanced resistance of the cry'- 
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dehydroamino acid residue to enzymatic degrada- 
tions. Cyclization of the peptide sequence is also 
one way of restricting the conformation, and many 
cyclic peptides have been found to be biologically 
active due to a unique conformation enforced by 
their cyclic structure. Although crfl-dehydroamino 
acids have often been incorporated into bioactive 
peptides with a linear sequence, it is more likely 
that cyclization of such peptides introduces addi- 
tional structural restrictions. Stabilization of 
bioactive conformations would provide a powerful 
strategy for designing an analog useful for clarify- 
ing the mechanism of bioactive ligand-receptor in- 
teractions. 
Gramicidin S (GS), a cyclic decapeptide an- 
tibiotic active against Gram-positive bacteria, has 
a unique B-sheet structure with type II'/Y-turns at 
the sequences of Leu-D-Phe-Pro-Val. If the D- 
Phe 4,4, residues are replaced by their 
dehydrogenated derivative, namely dehydrophe- 
nylalanine (APhe), the 13-turn structure of GS 
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would be rigidly constrained tostabilize the ZY-sheet 
conformation, resulting in the retention or even 
enhancement of GS bioactivity. Recent studies by 
Bach et al. [2,3] indeed indicate that the APhe 
residue in small cyclic peptides can sustain the ~- or 
-r-turn structure dictated by D-Phe. Thus, we have 
synthesized [zIPhe4'4']GS (fig.l) by the conven- 
tional solution method to evaluate the effects of 
this replacement on both conformation and bio- 
logical activity. We first synthesized Dnp-Leu- 
APhe-Pro-Val-pNA and recorded its CD spectrum 
in order to assess the capability of the APhe residue 
of forming a/Y-turn structure. Focusing on the 
structure or conformation-activity relationship, we 
report herein the synthesis and antimicrobial c- 
tivity of [APhe4'4']GS. 
2. EXPERIMENTAL 
2.1. Peptide synthesis 
The AtPhe moiety was introduced by spon- 
taneous ce,6'-dehydrogenation and azlactonization 
of Boc-Leu-DL-fl-phenylserine, yi lding Boc-Leu- 
APhe azlactone [4]. The Z configuration of the 
A Phe moiety was retained uring all synthetic steps 
as shown by ~H-NMR. The incubation of the 
azlactone with H-Pro-OMe yielded a tripeptide 
Boc-Leu-APhe-Pro-OMe. For the synthesis of 
Dnp-Leu-APhe-Pro-Val-pNA, this tripeptide was 
saponified to couple with H-Val-pNA. Purified 
Boc-Leu-APhe-Pro-Val-pNA was treated with 
TFA, and the resulting peptide-pNA was coupled 
with 1-fluoro-2,4-dinitrobenzene to yield the 
desired Dnp-dehydrotetrapeptide-pNA. The 
saturated peptide Dnp-Leu-D-Phe-Pro-Val-pNA 
was a generous gift from Drs K. Sato and U. 
Nagai. 
For the synthesis of [APhe4'4']GS, the Boc-Leu- 
APhe-Pro-OMe obtained above was elongated 
stepwise (50-84% yield) to afford Boc-Val- 
Orn(HCO)-Leu-APhe-Pro-OMe by using the 
water-soluble carbodiimide and 1-hydroxyben- 
zotriazole. This dehydropentapeptide ester was 
converted to the corresponding active ester after 
5 1 2 3 4 FPro '--Va] --Orn --Leu --APhe ] 
Lz~Phe4' Leu3'_OrnZ'_vall'_Pr05/ 
Fig.l. Primary structure of [APhe4'4'GS. 
successive saponification, esterification by N-hy- 
droxysuccinimide and water-soluble carbodiimide 
and TFA treatment. Cyclization of the active ester 
H-Val-Orn(HCO)-Leu-APhe-Pro-ONSu • TFA was 
carried out in pyridine (3 x 10 -3 M). It was found 
that this cyclization afforded exclusively the 
dimeric peptide of [Orn(HCO) 2'2',APhe4'4']GS, as 
demonstrated by paper electrophoresis of the 
deformylated product [7]. Treatment of the Orn- 
formylated analog with 0.5 M HCI/MeOH gave 
[APhe4'4']GS. [Orn(CHO)2'2']GS was prepared 
from natural GS by formylation with HCO-ONSu. 
The purity of [APhea'4']GS was confirmed by 
elemental analysis, paper electrophoresis, TLC 
and amino acid analysis. 
2.2. CD measurements 
CD spectra of the peptides were measured in 
spectrograde methanol using a Jasco J-40A 
automatic recording spectropolarimeter. A quartz 
cell with 1 mm path length was used. 
2.3. 3H-NMR measurements 
~H-NMR spectra were recorded on a Jeol JNM- 
GX-270 spectrometer, operating at 270 MHz using 
Fourier transfer techniques. Chemical shifts were 
determined using tetramethylsilane as an internal 
standard. GS and its analogs were dissolved in 
dimethyl sulfoxide-d6 (DMSO-d6) at 10 mM for 
the NMR samples. The signals of protons of each 
peptide were assigned by two-dimensional NMR 
measurements u ing the programs whose data 
matrices consist of 1024 points in t2 and 256 t~ 
values zero-filled to 512 points before transforma- 
tion. NOEs were measured by selectively gated ir- 
radiation (2 s) and pulse width 13.4 ms (90 ° flip 
angle). 
2.4. Microbial assays 
For determination of the minimum concentra- 
tion (ug/ml) necessary for complete inhibition of 
various bacteria, the peptides were examined by a 
dilution method utilizing a trypticase soy agar. 
3. RESULTS AND DISCUSSION 
By measuring the CD spectra of Dnp- 
tetrapeptide-pNA, Sato et al. [5] have recently 
reported a procedure to estimate the contribution 
of g-turn conformation to a given tetrapeptide. It 
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was found that the CD spectrum of Dnp-Leu-D- 
Phe-Pro-Val-pNA in methanol is typical of a/y- 
turn conformation. We then synthesized its un- 
saturated analog, Dnp-Leu-zaPhe-Pro-Val-pNA, 
to estimate the/y-turn preference of the Leu-APhe- 
Pro-Val sequence by comparing the CD spectra of 
the saturated and unsaturated peptides. Although 
APhe-containing peptide xhibited shifted Cotton 
effects presumably due to the APhe chromophore 
itself, both D-Phe and APhe-containing tetrapep- 
tides showed similar CD profiles especially in the 
range 300-400 nm, indicating the existence of/Y- 
turn structure (fig.2). From this result it was 
strongly expected that fragments Leu-APhe-Pro- 
Val in [APhe4'4']GS, as well as its saturated frag- 
ment in natural GS, would form a/?-bend to build 
the/y-sheet backbone conformation [6]. 
Sequence-dependent cyclic mono- or dimeriza- 
tion of linear precursors having pentapeptide s - 
quence of GS has been examined to find a 
sequence giving the exclusive dimeric cyclization, 
in relation to a position of possible/y-bend in linear 
pentapeptide precursors [7]. In the present study, 
exclusive formation of the cyclic decapeptide 
[Orn(HCO)E'2',APhe4'4']GS by cyclization of the 
pentapeptide H-Val-Orn(HCO)-Leu-zaPhe-Pro- 
ONSu indicates further a very strong driving force 
of the APhe-Pro sequence to form a /y-bend 
structure. 
The most important structural characteristic for 
antimicrobial ctivity of GS is the antiparallel/y- 
sheet conformation with four intramolecular 
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Fig.2. CD spectra of Dnp-tetrapeptide-pNA. Solvent: 
MeOH. Curves: ( - - - )  Dnp-Leu-D-Phe-Pro-Val-pNA; 
( ) Dnp-Leu-A Phe-Pro-Val-pNA. 
hydrogen bonds between the Val and Leu residues 
[6]. The/y-sheet backbone conformation confers 
on GS the amphiphilic ring structure, in which the 
side chains of Val ]'1' and Leu 3'3' form a 
hydrophobic site and the side chains of Orn 2'2' 
form a hydrophilic site on the other side of the ring 
[6]. This structural feature appears to be associated 
directly with the antibiotic activity. In this study, 
for the structural comparison of saturated and un- 
saturated gramicidin S, ]H-NMR studies 
(270 MHz, in DMSO-d6) were performed for 
[Orn(HCO)2'2'] - and [Orn(HCO)2'2',APhe4'4'IGS 
and natural GS. In the NOE experiments, 
[Orn(HCO)2'2' ,A Phe4'4']GS showed distinct 
NOEs (5-20070) between protons of such pairs as 
APhe 4 NH and Leu 3 C,,I-I, Orn 2 aNH and Val 1 
C,H, Leu 3 NHand Orn 2 C,~H. and Val 1 NFI and 
Pro 5 C~H(fig.3). These effects were also observed 
for saturated GS, and Rae et al. [8] and Gibbons 
et al. [9] have reported them as evidence in favor 
of the/y-sheet backbone conformation of natural 
GS. 
Temperature dependence studies further sup- 
ported the conformational similarity between 
saturated and unsaturated gramicidin S. As shown 
in fig.4, all of the three peptides howed very 
similar temperature dependences for each amino 
proton. Among them, the Val L'' and Leu 3'3' 
amide protons exhibited small values of dependen- 
cy (0.7-3.2 x 10 -3 ppm/°C), indicating that these 
protons are solvent-shielded or H-bonded. It 
should be noted, however, that the Val 1'~' amide 
protons of the unsaturated peptide have an ex- 
tremely low temperature dependence (0.7 x 
10 -3 ppm/°C) as compared with those of 
saturated analogs (2.3-2.5 × 10-3ppm/°C). 
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Fig.3. Conformation of [APhe4'4']GS. 
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Fig.4. Temperature dependences of amide proton 
chemical shifts of GS. 2HCI (I), [Orn(CHO)2'2']GS (II), 
and [Orn(CHO)2'2',~Phe4'4']GS ( I I I ) in DMSO-d6. 
Numbers on the lines refer to 103x temperature 
coefficient in ppm. °C -1. 
Moreover, from the comparative studies of the 
chemical shifts, it was found that the NMR spec- 
trum of the unsaturated analog shows fairly large 
lower-field shifts (0.24-0.30 ppm) of VaI-NH and 
Leu-C=H in addition to a very large lower-field 
shift (1.77 ppm) of APhe-NH. These shifts should 
be explained by the change in electron density 
around the APhe residue and also around the 
hydrogen bond between Val-NH and Leu-CO. The 
latter change must be due to a constrictive ffect, 
which is caused by a,,fl-dehydrogenation associated 
with spLsp 2 conversion of the ring structure of 
Leu-D-Phe-Pro-Val bridged by a VaI-NH. Leu-CO 
hydrogen bond. These results together with data 
Table 1 
Antimicrobial activity of gramicidin S and 
[APhe4'4']gramicidin S 
Strain Minimum inhibitory 
concentration (ug/ml) 
GS [zlPhe4'4']GS 
Staphylococcus aureus 
FDA 109A 6.25 6.25 
Bacillus subtilis PCI 219 3.13 6.25 
Shigella sonnei EW-33 25 25 
Escherichia coli NIHJ JC-2 > 100 > 100 
Escherichia coli O-111 > 100 > 100 
on temperature dependence suggest that the 
hydrogen bond between Val-NH and Leu-CO is 
strengthened, resulting in the reinforcement of a 
backbone conformation of GS (fig.3). Obviously, 
deformylation of [Orn(HCO) 2'2' ~Phe4'4']GS 
yields the analog [APhe4'4'IGS having an am- 
phiphilic nature because of the fl-sheet backbone 
conformation. 
The antimicrobial activity of GS and 
[APhe4'4']GS is shown in table 1. Like natural GS, 
[APhe4'4']GS is very active for Gram-positive 
bacteria, such as Staphylococcus aureus and 
Bacillus subtilis, but not for Gram-negative ones, 
such as E. coli. The potency levels shown by the 
minimum inhibitory concentration are almost the 
same for each bacterium between saturated GS and 
unsaturated [APhe4'4']GS. This strong antibiotic 
activity of [zaPhe4'4']GS must be due to a rein- 
forced fl-sheet backbone conformation with an 
amphiphilic nature. 
The present study shows that conformational 
stabilization can be attained by tr,~-dehy- 
drogenation of the amino acid residue(s) of bioac- 
tive peptides. Such structural modifications clarify 
the molecular mechanism of interactions between 
peptide ligands and their receptors. 
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